ERS International Congress 2021: highlights from the Epidemiology and Environment Assembly.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
13
12
2021
accepted:
25
01
2022
entrez:
26
5
2022
pubmed:
27
5
2022
medline:
27
5
2022
Statut:
epublish
Résumé
In this article, early career members of the Epidemiology and Environment Assembly of the European Respiratory Society (ERS) summarise a selection of four sessions from the Society's 2021 virtual congress. The topics covered focus on chronic respiratory disease epidemiology, the health effects of tobacco and nicotine, and the respiratory health impact of environmental exposures and climate change. While the burden of chronic respiratory diseases such as COPD is expected to increase in the next decades, research on modifiable risk factors remains key. The tobacco and nicotine research presented here focuses on recent evolutions in cigarette alternatives, including vaping and the use of heated tobacco products, and changes in behaviours related to the coronavirus disease 2019 pandemic. The 2021 World Health Organization air quality guidelines were also a major topic of the congress. Despite their benefits, challenges remain in driving and implementing environmental health policies to take into account the respiratory effects observed at very low air pollution concentrations, as well as the impact of climate change on environmental exposures.
Identifiants
pubmed: 35615413
doi: 10.1183/23120541.00697-2021
pii: 00697-2021
pmc: PMC9126047
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©The authors 2022.
Déclaration de conflit d'intérêts
Conflict of interest: M. Bosch de Basea has nothing to disclose. Conflict of interest: A.B. Belachew has nothing to disclose. Conflict of interest: M. Jankowski has nothing to disclose. Conflict of interest: H. Meteran reports lecture honoraria and consultancy fees from GSK, TEVA, Norvatis and ALK-Abelló in the past 36 months and outside the submitted work. Conflict of interest: O. Dumas has nothing to disclose.
Références
Eur Respir J. 2015 Jan;45(1):38-50
pubmed: 25193994
Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339
pubmed: 29779416
Eur Respir J. 2021 Jun 4;57(6):
pubmed: 34088754
Respir Res. 2011 Jan 10;12:5
pubmed: 21219618
Environ Int. 2020 Oct;143:105974
pubmed: 32703584
N Engl J Med. 2014 Oct 2;371(14):1285-94
pubmed: 25196117
Environ Int. 2017 Mar;100:1-31
pubmed: 27881237
Allergy. 2020 Sep;75(9):2170-2184
pubmed: 31916265
Tob Induc Dis. 2008 Dec 18;4:12
pubmed: 19094204
Environ Int. 2020 Oct;143:105901
pubmed: 32634667
Environ Epidemiol. 2021 Jul 01;5(4):e162
pubmed: 34414346
J Med Virol. 2021 Feb;93(2):1045-1056
pubmed: 32749705
World Allergy Organ J. 2020 Jan 06;13(1):100096
pubmed: 32071664
Eur Respir J. 2011 Mar;37(3):508-15
pubmed: 20595157
Int J Epidemiol. 2001 Jun;30(3):427-32; discussion 433-4
pubmed: 11416056
MMWR Morb Mortal Wkly Rep. 2012 Nov 9;61(44):889-94
pubmed: 23134971
Allergy. 2016 Oct;71(10):1461-71
pubmed: 27087129
Arch Intern Med. 2004 Nov 8;164(20):2206-16
pubmed: 15534156
Eur Respir J. 2021 Dec 2;58(6):
pubmed: 33986028
Environ Int. 2021 May;150:106434
pubmed: 33601225
Int J Environ Res Public Health. 2018 Nov 13;15(11):
pubmed: 30428525
Thorax. 2021 Sep;76(9):880-886
pubmed: 33632767
Environ Int. 2020 Sep;142:105876
pubmed: 32590284
Nicotine Tob Res. 2022 Feb 14;24(3):395-399
pubmed: 34519792
Pediatr Med. 2021 Feb;4:
pubmed: 34095814
Int J Environ Res Public Health. 2021 Feb 17;18(4):
pubmed: 33671203
Environ Int. 2020 Nov;144:105998
pubmed: 33032072
J Pathol. 2021 Jan;253(1):17-30
pubmed: 32991738
Environ Int. 2021 May;150:106435
pubmed: 33601224
Lancet Public Health. 2020 Nov;5(11):e577
pubmed: 33120038
Environ Res. 2017 Nov;159:212-221
pubmed: 28803150
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1357-64
pubmed: 24076757
Addiction. 2021 May;116(5):1233-1244
pubmed: 33089562
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36
pubmed: 33146552
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540